-+ 0.00%
-+ 0.00%
-+ 0.00%

GE HEALTHCARE: MANGACICLANOL MET PRIMARY ENDPOINT WITH SIMILAR DIAGNOSTIC PREFERENCE TO GADOBUTROL

Reuters·11/19/2026 12:58:24

Please log in to view news